Search
for
Sort by
Research 30 of 1000+
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Off-label dermatologic uses of IL-23 inhibitors
- Association of Serum IL-23 and IL-17 Levels with Alopecia Areata
- Association of Serum IL-23 and IL-17 Levels with Alopecia Areata
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Hair Loss Associated With IL ‐17 and IL ‐23 Inhibitors: A Systematic Review
- Cutting Edge: Memory Regulatory T Cells Require IL-7 and Not IL-2 for Their Maintenance in Peripheral Tissues
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- 1318 Both lesional and non-lesional skin from acne patients shows robust IL-17-skewing and upregulation of antimicrobial peptides
- Chemical Constituents from Osmanthus fragrans var. aurantiacus Makino with Their In Vitro and In Silico Studies Target Anti-Inflammation by Suppressing ERK 1/2 MAPK Signaling
- Type 2 innate immunity regulates hair follicle homeostasis to control <i>Demodex</i> pathosymbionts
- 24 ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- What causes hidradenitis suppurativa ?—15 years after
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Autoimmunity and autoimmune co-morbidities in psoriasis
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications